Comparing Critical Care Admissions Among Urban Populations Before and During the COVID-19 Pandemic

Panagis Galiatsatos1, Kathleen R Page1, Souvik Chatterjee1

  • 1Panagis Galiatsatos, MD, MHS, and Souvik Chatterjee, MD, are Assistant Professors and Edward S. Chen, MD, is an Associate Professor, Division of Pulmonary and Critical Care Medicine; Kathleen R. Page, MD, is an Associate Professor, Division of Infectious Diseases; Felicia Hill-Briggs, PhD, is a Professor, Division of General Internal Medicine; and Sherita H. Golden, MD, MHS, is a Professor, Division of Endocrinology, Diabetes, and Metabolism; all in the Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. Panagis Galiatsatos and Felicia Hill-Briggs are Co-Chairs, Johns Hopkins Health Equity Steering Committee; April Lugo is a Program Specialist; and Sherita H. Golden is Director; all in the Office of Diversity, Inclusion, and Health Equity, Johns Hopkins Medicine, Baltimore, MD. Sherita H. Golden is also Lead, Armstrong Institute for Patient Safety and Quality, Johns Hopkins Medicine, Baltimore, MD. Panagis Galiatsatos is Co-Director, Medicine for the Greater Good; and Joyce Maygers, DNP, RN, is a Senior Clinical Outcomes Coordinator, Department of Care Management; both at Johns Hopkins Bayview Medical Center, Baltimore, MD. Sauradeep Sarker, MD, is an Internal Medicine Resident, Department of Medicine, Sinai Hospital, Baltimore, MD. Vanya Jones, PhD, is an Associate Professor, Health, Behavior, and Society; Felicia Hill-Briggs and Sherita H. Golden are Professors of Medicine, Welch Center for Prevention, Epidemiology, and Clinical Research; and Sherita H. Golden is a Professor, Department of Epidemiology; all at the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Tina Tolson, RN, is Director, Johns Hopkins Medicine Language Services, Johns Hopkins Health System, Baltimore, MD.

Health Security
|May 4, 2021
PubMed

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
603
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
504
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
264
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
440
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
376
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
72